Dianthus Therapeutics (DNTH) Market Capitalization (2018 - 2025)
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Market Capitalization (2018 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Dianthus Therapeutics | 4.09 Bn | 3.69 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.77 Bn |
| Sep 30, 2025 | 1.69 Bn |
| Jun 30, 2025 | 599.45 Mn |
| Mar 31, 2025 | 582.76 Mn |
| Dec 31, 2024 | 678.31 Mn |
| Sep 30, 2024 | 804.05 Mn |
| Jun 30, 2024 | 759.63 Mn |
| Mar 31, 2024 | 880.46 Mn |
| Dec 31, 2023 | 53.60 Mn |
| Sep 30, 2023 | 53.41 Mn |
| Jun 30, 2023 | 46.10 Mn |
| Mar 31, 2023 | 47.91 Mn |
| Dec 31, 2022 | 24.26 Mn |
| Sep 30, 2022 | 85.38 Mn |
| Jun 30, 2022 | 70.56 Mn |
| Mar 31, 2022 | 170.52 Mn |
| Dec 31, 2021 | 260.48 Mn |
| Sep 30, 2021 | 427.90 Mn |
| Jun 30, 2021 | 572.22 Mn |
| Mar 31, 2021 | 575.46 Mn |